Literature DB >> 3342905

Galactose inhibition of ovulation in mice.

W J Swartz1, D R Mattison.   

Abstract

Clinical evidence suggests an association between galactosemia and premature ovarian failure. In the present study, adult female mice were fed a diet consisting of 50% galactose for either 2, 4, or 6 weeks. At all times there was a decrease in the normal ovulatory response, as evidenced by a reduction in the number of corpora lutea when compared with controls. Additionally, the exposure of galactose-treated mice to a superovulatory regimen of pregnant mare's serum gonadotropin (PMSG) and human chorionic gonadotropin (hCG) failed to induce an increased ovulatory response. Morphologic alterations, such as the increase in interstitial tissue and the appearance of lipofuscin, coupled with the failure to respond to exogenous gonadotropins, suggest that the reduced ovulatory response may be occurring at the level of the ovary. This effect, however, is reversible with cessation of galactose treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342905

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

Review 1.  Diet and fertility: a review.

Authors:  Audrey J Gaskins; Jorge E Chavarro
Journal:  Am J Obstet Gynecol       Date:  2017-08-24       Impact factor: 8.661

2.  Dairy intake in relation to in vitro fertilization outcomes among women from a fertility clinic.

Authors:  M C Afeiche; Y-H Chiu; A J Gaskins; P L Williams; I Souter; D L Wright; R Hauser; J E Chavarro
Journal:  Hum Reprod       Date:  2016-01-18       Impact factor: 6.918

3.  Dairy intake and fecundability in 2 preconception cohort studies.

Authors:  Lauren A Wise; Amelia K Wesselink; Ellen M Mikkelsen; Heidi Cueto; Kristen A Hahn; Kenneth J Rothman; Katherine L Tucker; Henrik Toft Sørensen; Elizabeth E Hatch
Journal:  Am J Clin Nutr       Date:  2016-11-30       Impact factor: 7.045

4.  Induction of a rat model of premature ovarian insufficiency using D-galactose feeding during the critical periods of development: A pilot study.

Authors:  Marzieh Rostami Dovom; Mahsa Noroozzadeh; Nariman Mosaffa; Abbas Piryaei; Azita Zadevakili; Mohammad Amin Abdollahifar; Fahimeh Ramezani Tehrani
Journal:  Int J Reprod Biomed       Date:  2022-05-23

5.  Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes.

Authors:  Melissa A Merritt; Daniel W Cramer; Allison F Vitonis; Linda J Titus; Kathryn L Terry
Journal:  Int J Cancer       Date:  2012-07-24       Impact factor: 7.396

6.  Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer.

Authors:  Melissa A Merritt; Elizabeth M Poole; Susan E Hankinson; Walter C Willett; Shelley S Tworoger
Journal:  Cancer Causes Control       Date:  2014-04-11       Impact factor: 2.506

Review 7.  Gonadal function in galactosemics and in galactose-intoxicated animals.

Authors:  J B Gibson
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 8.  Ovarian function in girls and women with GALT-deficiency galactosemia.

Authors:  Judith L Fridovich-Keil; Cynthia S Gubbels; Jessica B Spencer; Rebecca D Sanders; Jolande A Land; Estela Rubio-Gozalbo
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

9.  Ovotoxic effects of galactose involve attenuation of follicle-stimulating hormone bioactivity and up-regulation of granulosa cell p53 expression.

Authors:  Sayani Banerjee; Pratip Chakraborty; Piyali Saha; Soma Aditya Bandyopadhyay; Sutapa Banerjee; Syed N Kabir
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

Review 10.  Fertility preservation in female classic galactosemia patients.

Authors:  Britt van Erven; Cynthia S Gubbels; Ron J van Golde; Gerard A Dunselman; Josien G Derhaag; Guido de Wert; Joep P Geraedts; Annet M Bosch; Eileen P Treacy; Corrine K Welt; Gerard T Berry; M Estela Rubio-Gozalbo
Journal:  Orphanet J Rare Dis       Date:  2013-07-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.